PL2736920T3 - Związek hamujący przekazywanie sygnałów przez szlak Notch - Google Patents
Związek hamujący przekazywanie sygnałów przez szlak NotchInfo
- Publication number
- PL2736920T3 PL2736920T3 PL12741192T PL12741192T PL2736920T3 PL 2736920 T3 PL2736920 T3 PL 2736920T3 PL 12741192 T PL12741192 T PL 12741192T PL 12741192 T PL12741192 T PL 12741192T PL 2736920 T3 PL2736920 T3 PL 2736920T3
- Authority
- PL
- Poland
- Prior art keywords
- inhibitor compound
- signaling inhibitor
- notch pathway
- pathway signaling
- notch
- Prior art date
Links
- 102000005650 Notch Receptors Human genes 0.000 title 1
- 108010070047 Notch Receptors Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000037361 pathway Effects 0.000 title 1
- 230000011664 signaling Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512016P | 2011-07-27 | 2011-07-27 | |
| US201161560486P | 2011-11-16 | 2011-11-16 | |
| PCT/US2012/047100 WO2013016081A1 (en) | 2011-07-27 | 2012-07-18 | Notch pathway signaling inhibitor compound |
| EP12741192.4A EP2736920B1 (en) | 2011-07-27 | 2012-07-18 | Notch pathway signaling inhibitor compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2736920T3 true PL2736920T3 (pl) | 2015-11-30 |
Family
ID=46598983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12741192T PL2736920T3 (pl) | 2011-07-27 | 2012-07-18 | Związek hamujący przekazywanie sygnałów przez szlak Notch |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US8569286B2 (pl) |
| EP (1) | EP2736920B1 (pl) |
| JP (1) | JP6027110B2 (pl) |
| KR (1) | KR101578309B1 (pl) |
| CN (1) | CN103732612B (pl) |
| AP (1) | AP4080A (pl) |
| AR (1) | AR087107A1 (pl) |
| AU (1) | AU2012287251B2 (pl) |
| BR (1) | BR112014001600B1 (pl) |
| CA (1) | CA2841178C (pl) |
| CL (1) | CL2014000175A1 (pl) |
| CO (1) | CO6862159A2 (pl) |
| CR (1) | CR20140036A (pl) |
| CY (1) | CY1116645T1 (pl) |
| DK (1) | DK2736920T3 (pl) |
| DO (1) | DOP2014000011A (pl) |
| EA (1) | EA023044B1 (pl) |
| EC (1) | ECSP14013179A (pl) |
| ES (1) | ES2544937T3 (pl) |
| GT (1) | GT201400012A (pl) |
| HR (1) | HRP20150771T1 (pl) |
| HU (1) | HUE027534T2 (pl) |
| IL (1) | IL229988A (pl) |
| JO (1) | JO3148B1 (pl) |
| MA (1) | MA35611B1 (pl) |
| ME (1) | ME02171B (pl) |
| MX (1) | MX356536B (pl) |
| MY (1) | MY184303A (pl) |
| PE (1) | PE20141061A1 (pl) |
| PH (1) | PH12014500215B1 (pl) |
| PL (1) | PL2736920T3 (pl) |
| PT (1) | PT2736920E (pl) |
| RS (1) | RS54135B1 (pl) |
| SI (1) | SI2736920T1 (pl) |
| TW (1) | TWI568730B (pl) |
| WO (1) | WO2013016081A1 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10350216B2 (en) | 2013-01-14 | 2019-07-16 | The Trustees Of Columbia University In The City Of New York | Methods of treating, preventing and diagnosing leukemia and other blood diseases and disorders |
| CN105764501A (zh) | 2013-07-26 | 2016-07-13 | 现代化制药公司 | 改善比生群治疗效益的组合物 |
| TWI704151B (zh) | 2014-12-22 | 2020-09-11 | 美商美國禮來大藥廠 | Ｅｒｋ抑制劑 |
| TWI609687B (zh) | 2015-04-14 | 2018-01-01 | 美國禮來大藥廠 | 平滑肌肉瘤之標靶性治療 |
| JO3491B1 (ar) * | 2015-07-07 | 2020-07-05 | Audion Therapeutics | مركبات مثبطة لإشارات مسار notch |
| CR20180413A (es) | 2016-02-05 | 2018-12-04 | Denali Therapeutics Inc | Inhibidores de la proteína quinasa 1 que interactua con el receptor |
| SG10201913331VA (en) | 2016-03-15 | 2020-03-30 | Oryzon Genomics Sa | Combinations of lsd1 inhibitors for use in the treatment of solid tumors |
| RU2747788C2 (ru) * | 2016-04-12 | 2021-05-14 | Эли Лилли Энд Компани | Комбинированная терапия ингибиторами notch и cdk4/6 для лечения рака |
| RU2754452C2 (ru) * | 2016-04-12 | 2021-09-02 | Эли Лилли Энд Компани | Комбинированная терапия ингибиторами notch и pi3k/mtor для применения в лечении рака |
| WO2017200969A1 (en) * | 2016-05-20 | 2017-11-23 | Eli Lilly And Company | Combination therapy with notch and pd-1 or pd-l1 inhibitors |
| MX387397B (es) * | 2016-08-31 | 2025-03-18 | Lilly Co Eli | Régimen de dosificación para el tratamiento de tumores sólidos. |
| CA3039405A1 (en) | 2016-10-12 | 2018-04-19 | Eli Lilly And Company | Targeted treatment of mature t-cell lymphoma |
| JP7208137B2 (ja) | 2016-12-09 | 2023-01-18 | デナリ セラピューティクス インコーポレイテッド | 化合物、組成物および方法 |
| JP2020507605A (ja) | 2017-02-17 | 2020-03-12 | フレッド ハッチンソン キャンサー リサーチ センター | Ｂｃｍａ関連癌および自己免疫疾患の治療のための併用療法 |
| JP7447006B2 (ja) | 2017-11-01 | 2024-03-11 | ジュノー セラピューティクス インコーポレイテッド | Ｂ細胞成熟抗原（ｂｃｍａ）に特異的なキメラ抗原受容体 |
| EP3706754A1 (en) * | 2017-11-06 | 2020-09-16 | Juno Therapeutics, Inc. | Combination of a cell therapy and a gamma secretase inhibitor |
| MX2020011826A (es) * | 2018-05-06 | 2021-01-15 | Ayala Pharmaceuticals Inc | Composiciones de combinacion que comprenden compuestos de bisfluoroalquil-1,4-benzodiazepinona y metodos de uso de las mismas. |
| MX2021003773A (es) | 2018-10-02 | 2021-07-16 | Frequency Therapeutics Inc | Composiciones farmacéuticas y métodos relacionados con los agentes terapéuticos óticos. |
| PH12021552572A1 (en) | 2019-04-08 | 2022-06-20 | Frequency Therapeutics Inc | Combination of chir99021 and valproic acid for treating hearing loss |
| IL314082A (en) | 2022-01-12 | 2024-09-01 | Denali Therapeutics Inc | Crystal forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazapin-3-yl)- H4- 1,2,4-triazole-3-carboxamide |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI0951466T1 (sl) * | 1996-12-23 | 2009-10-31 | Elan Pharm Inc | Cikloalkili, laktami, laktoni in sorodne spojine, farmacevtske zmesi, ki jih vsebujejo, in metode inhibicije sproščanja beta-amiloidnega peptida in/ali njegove sinteze z uporabo takih spojin |
| CA2325389A1 (en) * | 1998-06-22 | 1999-12-29 | James E. Audia | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| WO1999067219A1 (en) | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| DE602004015415D1 (de) | 2003-02-04 | 2008-09-11 | Hoffmann La Roche | Malonamidderivate als gamma-secretaseinhibitoren |
| DE602004020680D1 (de) | 2003-09-09 | 2009-05-28 | Hoffmann La Roche | Die aktivität von gamma-secretase blockierende malonamidderivate |
| DK1673347T3 (en) | 2003-10-06 | 2015-10-12 | Hoffmann La Roche | SUBSTITUTED DIBENZO-AZEPINE AND BENZO-DIAZEPINE DERIVATIVES USED AS GAMMA SECRETASE INHIBITORS |
| EP2018368B1 (en) | 2006-03-27 | 2012-12-05 | F. Hoffmann-La Roche AG | Malonamide derivatives as gamma secretase inhibitors |
| JP2010517954A (ja) * | 2007-02-02 | 2010-05-27 | エフ．ホフマン−ラ ロシュ アーゲー | ６−オキソ−６，７−ジヒドロ−５Ｈ−ジベンゾ［ｂ，ｄ］アゼピン−７−イル誘導体 |
| CN101909633B (zh) | 2008-01-11 | 2012-05-30 | 霍夫曼-拉罗奇有限公司 | γ-分泌酶抑制剂用于治疗癌症的应用 |
| WO2011060051A1 (en) * | 2009-11-12 | 2011-05-19 | University Of Massachusetts | Methods for treating glioblastoma |
-
2012
- 2012-07-10 AR ARP120102486A patent/AR087107A1/es not_active Application Discontinuation
- 2012-07-10 JO JOP/2012/0190A patent/JO3148B1/ar active
- 2012-07-13 TW TW101125459A patent/TWI568730B/zh active
- 2012-07-18 CA CA2841178A patent/CA2841178C/en active Active
- 2012-07-18 DK DK12741192.4T patent/DK2736920T3/en active
- 2012-07-18 ME MEP-2015-105A patent/ME02171B/me unknown
- 2012-07-18 AP AP2014007362A patent/AP4080A/en active
- 2012-07-18 WO PCT/US2012/047100 patent/WO2013016081A1/en not_active Ceased
- 2012-07-18 SI SI201230246T patent/SI2736920T1/sl unknown
- 2012-07-18 PE PE2014000129A patent/PE20141061A1/es active IP Right Grant
- 2012-07-18 HU HUE12741192A patent/HUE027534T2/en unknown
- 2012-07-18 BR BR112014001600-3A patent/BR112014001600B1/pt active IP Right Grant
- 2012-07-18 CN CN201280037471.9A patent/CN103732612B/zh active Active
- 2012-07-18 PL PL12741192T patent/PL2736920T3/pl unknown
- 2012-07-18 MX MX2014001084A patent/MX356536B/es active IP Right Grant
- 2012-07-18 RS RS20150496A patent/RS54135B1/sr unknown
- 2012-07-18 EP EP12741192.4A patent/EP2736920B1/en active Active
- 2012-07-18 US US13/551,681 patent/US8569286B2/en active Active
- 2012-07-18 PH PH1/2014/500215A patent/PH12014500215B1/en unknown
- 2012-07-18 HR HRP20150771TT patent/HRP20150771T1/hr unknown
- 2012-07-18 AU AU2012287251A patent/AU2012287251B2/en active Active
- 2012-07-18 EA EA201490161A patent/EA023044B1/ru not_active IP Right Cessation
- 2012-07-18 KR KR1020147001731A patent/KR101578309B1/ko active Active
- 2012-07-18 ES ES12741192.4T patent/ES2544937T3/es active Active
- 2012-07-18 PT PT127411924T patent/PT2736920E/pt unknown
- 2012-07-18 MY MYPI2014700183A patent/MY184303A/en unknown
- 2012-07-18 JP JP2014522877A patent/JP6027110B2/ja active Active
-
2013
- 2013-12-17 IL IL229988A patent/IL229988A/en active IP Right Grant
-
2014
- 2014-01-22 DO DO2014000011A patent/DOP2014000011A/es unknown
- 2014-01-22 MA MA36712A patent/MA35611B1/fr unknown
- 2014-01-23 CL CL2014000175A patent/CL2014000175A1/es unknown
- 2014-01-24 GT GT201400012A patent/GT201400012A/es unknown
- 2014-01-24 CR CR20140036A patent/CR20140036A/es unknown
- 2014-01-24 CO CO14014585A patent/CO6862159A2/es active IP Right Grant
- 2014-01-27 EC ECSP14013179 patent/ECSP14013179A/es unknown
-
2015
- 2015-08-25 CY CY20151100742T patent/CY1116645T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP4080A (en) | Notch pathway signaling inhibitor compound | |
| IL265897A (en) | Transformed imidazopyridinyl – aminopyridine compounds | |
| ZA201400232B (en) | Metalloenzyme inhibitor compounds | |
| LT2892889T (lt) | Inhibitoriaus junginiai | |
| EP2723730A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
| ZA201401553B (en) | Cyclopropaneamine compound | |
| ZA201408141B (en) | Substituted tetrahydroisoquinoline compounds as factor xia inhibitors | |
| ZA201306580B (en) | Cyclopropylamines as lsd1 inhibitors | |
| LT2788343T (lt) | Metalo fermentus slopinantys junginiai | |
| GB201106817D0 (en) | New compound | |
| EP2708540A4 (en) | PYRIMIDO-DIAZEPINONE COMPOUND | |
| EP2751117A4 (en) | METALLOENZYMHEMMERVERBINDUNGEN | |
| GB201211019D0 (en) | Inhibitor compounds | |
| GB201104669D0 (en) | Compound | |
| GB201108188D0 (en) | Corrosion inhibitor | |
| GB201120474D0 (en) | Inhibitors | |
| GB201104399D0 (en) | Novel inhibitors | |
| GB201004308D0 (en) | New inhibitor compounds | |
| GB201100461D0 (en) | Quenching compound | |
| GB201121538D0 (en) | Compound | |
| GB201118102D0 (en) | Compound |